NeuroScent

NeuroScent sells functional fine-mist room and body sprays, roll-on “mood oils,” and waterless diffuser tablets that pair curated fragrance accords with patented olfactory accords shown in third-party EEG studies to shift brain-wave activity toward calm, focus, or energy. Prices sit in the mid-range: 50 ml sprays $28, 10 ml roll-ons $24, 6-pack diffuser tablets $22. Distribution is DTC through neuroscent.com and a subscription app; select Equinox, Saks, and Erewhon locations carry limited SKUs on test-and-buy end-caps. The brand’s IP is a library of 18 olfactory accords (e.g., L-theanine + valencene, beta-caryophyllene + limonene) micro-encapsulated to release over 4 h; each batch is GC-MS verified and backed by double-blind studies run with the University of Cincinnati’s Center for Cognition. Best-sellers are the 3 pm “Focus” desk spray and the bedtime “Slow Wave” pillow mist, both of which sold 40 k units in 2023 and are frequently cited in productivity-podcast gift guides. Core buyers are 25-45 y.o. knowledge workers who track sleep and HRV, shop clean beauty, and want evidence-backed wellness hacks that fit a minimalist routine. They value data over storytelling, will pay for peer-reviewed claims, and post screenshot “before/after” Oura ring scores in Reddit nootropics threads. NeuroScent competes with both premium niche fragrance houses and wellness-tech aromatherapy start-ups; it differentiates by publishing peer-reviewed brain-map data, using fragrance-grade perfumery aesthetics rather than earthy-hippie cues, and offering an app that prompts timed micro-doses synced to calendar events—positioning scent as a quantified self-tool instead of a luxury indulgence.